Frequently Asked Questions
The market is segmented based on Global Single-Use Bioreactors Market, By Product (Single-use Bioreactors System, Single-use Media Bag, Single-use Filtration Assemblies), Type (Stirred Tank Single-use Bioreactors, Bubble Column Single-use Bioreactors, Wave Induced Single-use Bioreactors), Type of Molecule (Monoclonal Antibodies (MAbs), Vaccine, Stem Cells, Gene–Modified Cells, Other Molecules), Cell Type (Mammalian Cells, Bacteria Cells, Yeast Cells, Other Cells), Application (Research and Development, Process Development, Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)) – Industry Trends and Forecast to 2030.
.
The Global Single Use Bioreactors Market size was valued at USD 5.79 USD Billion in 2022.
The Global Single Use Bioreactors Market is projected to grow at a CAGR of 16.05% during the forecast period of 2023 to 2030.
The major players operating in the market include Merck KGaA, CESCO BIOENGINEERING CO., GENERAL ELECTRIC, Solida Biotechnology GmbH, Applikon Biotechnology, Danaher, Celltainer, Pierre Guérin, Cellexus Ltd, Esco Micro Pte , Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Distek , PBS Biotech , PARKER HANNIFIN CORP, ABEC, DCI, Biolafitte.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa.
